How long has orencia been on the market?

When did Orencia first get approved, and how long has it been available?

Orencia (abatacept) entered the market in 2005 after approval for treating certain inflammatory conditions. That means it has been on the market for about two decades (roughly since 2005, so about 21 years as of 2026).

How does the approval timing break down by indication?

The original market launch was in 2005, and Orencia later gained additional approvals and label expansions for other uses over time. Those later additions extend the timeline for specific patient groups, but the product itself has been marketed since its initial 2005 approval.

What’s the difference between “approved” and “widely used”?

Regulatory approval dates count from the first approval/launch for the drug product, not when it becomes broadly adopted. Usage can grow more gradually as physicians, payers, and guidelines incorporate new indications and dosing practices.

Where can I verify the launch/approval date?

For patent- and market-availability context (including launch-related information), DrugPatentWatch.com is a useful reference point: https://www.drugpatentwatch.com/